Silver Book Fact

Of the 8 Million older Americans at high risk of developing advanced age-related macular degeneration (AMD), 1.3 million will develop advanced AMD within 5 years.  However the NEI-sponsored Age-Related Eye Disease Study (AREDS) nutritional formula could help 300,000 of those 1.3 million avoid the severe vision loss of advanced AMD over a 5-year period.

Bressler N, Bressler S, Congdon N, Ferris F, et al. Potential Public Health Impact of Age-Related Eye Disease Study Results: AREDS report no. 11. Arch Opthalmol. 2003; 121(11): 1621-4. http://jamanetwork.com/journals/jamaophthalmology/fullarticle/415852

Reference

Title
Potential Public Health Impact of Age-Related Eye Disease Study Results: AREDS report no. 11
Publication
Arch Opthalmol
Publication Date
2003
Authors
Bressler N, Bressler S, Congdon N, Ferris F, et al.
Volume & Issue
Volume 121, Issue 11
Pages
1621-4
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • Screening and treatment of diabetic retinopathy in type 2 diabetes patients produces annual savings of $247.9 million to the federal budget– in 1994 dollars.  
  • Treatment costs for a patient with early-stage glaucoma are about $2,000 less than those of a patient diagnosed with a later stage of the disease.  
  • Current treatments for proliferative diabetic retinopathy have reduced the rate of blindness within 5 years from 50% to less than 5%.  
  • Omega-3 polyunsaturated fatty acids have been found to protect against the development and progression of deterioration of the retina (retinopathy).  
  • Laser treatment and vitrectomy reduce the risk of blindness in patients with severe diabetic retinopathy by 90%.